Consort Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 25 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 M
- Revenue Growth 49.77%
- Profit Growth -33.99%
- Ebitda 140.76%
- Net Worth 3.60%
- Total Assets 9.17%
About Consort Laboratories
Consort Laboratories Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 October 1999 and has a history of 25 years and four months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.50 M.
Anupam Agarwal and Supriya Agarwal serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231UP1999PTC024796
-
Company No.
024796
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Oct 1999
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Consort Laboratories Private Limited offer?
Consort Laboratories Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Physiotherapy Equipment, Surgical & ICU Equipments, Defibrillators, CPAP, BiPAP Machine & Accessories.
Who are the key members and board of directors at Consort Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anupam Agarwal
|
Director | 01-Oct-1999 | Current |
|
Supriya Agarwal
|
Director | 31-Jan-2009 | Current |
Financial Performance of Consort Laboratories.
Consort Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.77% increase. The company also saw a substantial fall in profitability, with a 33.99% decrease in profit. The company's net worth moved up by a moderate rise of 3.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Consort Laboratories?
In 2022, Consort Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Consort Overseas Private LimitedAnupam Agarwal and Supriya Agarwal are mutual person
Charges (Loans)
₹3.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.30 Cr
- Bank Of Baroda : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2021 | Others | ₹3.00 M | Open |
| 08 Jul 2000 | Bank Of Baroda | ₹0.50 M | Open |
How Many Employees Work at Consort Laboratories?
Unlock and access historical data on people associated with Consort Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Consort Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Consort Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
